IRI Separation Technologies (TSX.V:IRI) is the manufacturer of a remarkable new dietary supplement that enhances the human body’s natural immune system through direct supplementation of actual antibodies . The product will be available in the United States and Canada under the brand name “Muno Boost” and will be available as an over-the-counter dietary supplement in pharmacies and through direct marketing.

I'm knee deep in my annual survey of pharmacy management in workers' comp, and if I look at one more column of data I'm going to need a few class 2's myself.

In an address to the Council of Teaching Hospitals in New Orleans, Wal-Mart's senior vice president and president of health and wellness, Dr. John Agwunobi will confirm a major milestone for the company's $4 prescription program. Since its launch in September 2006, the program walmart.com/pharmacy has now saved Americans more than $1 billion ($1,032,573,012.61 as of March 10, 2008).

Sweden’s pharmacy monopoly has all but given up on being paid the US$ 46.7 million it’s owed by customers who have charged their medications.

A device designed to eliminate mistakes made while mixing compounds at a hospital pharmacy was 100 percent accurate in identifying the proper formulations of seven intravenous drugs.

The Dutch Health Ministry said that it plans to extend its experimental medical marijuana program for five years.

Researchers at the University of North Carolina at Chapel Hill have patented a synthetic version of the drug heparin, called Recomparin, that is less complex chemically and should be easier to produce than previous forms.

Agencies worldwide are cracking down on counterfeit pharmaceuticals, and much of the focus has been on China, where an official was recently executed for approving fake medicines.

A review of previous studies indicates that an increase in prescription drug cost sharing is associated with a decrease in drug spending and use of pharmacies; and for some chronic conditions, higher cost sharing is associated with greater use of expensive medical services, according to an article in the July 4 issue of JAMA.

On July 2nd Walgreen Co. (NYSE, NASDAQ: WAG) and Option Care, Inc. (NASDAQ: OPTN) announced a definitive agreement in which Walgreens will acquire Option Care in a cash transaction for $19.50 per share.